Interferon beta-1a (also interferon beta-1-alpha) is a drug in the interferon family used to treat multiple sclerosis (MS).
It is produced by mammalian cells, while Interferon beta-1b is produced in modified E. coli.
Interferons have been shown to produce about a 18–38% reduction in the rate of MS relapses, and to slow the progression of disability in MS patients. There is currently no cure for MS, though starting a course of interferons early may slow its progress.
Interferon beta-1a is sold under the trade names Avonex (Biogen Idec) and Rebif (Merck Serono); CinnoVex (CinnaGen) is biosimilar.
Gate2Biotech - Biotechnology Portal - All Czech Biotechnology information in one place.
ISSN 1802-2685
This website is maintained by: CREOS CZ
© 2006 - 2024 South Bohemian Agency for Support to Innovative Enterprising (JAIP)
Interesting biotechnology content:
Enzyme biotechnology - Information about Enzyme biotechnology
Environmetal biotechnology - Information about environmetal biotechnology at Wikipedia
Researchers discover new clues to how tardigrades can survive intense radiation
Medical lab-on-a-chip runs 32 pathology tests at once